Transforming Growth Factor-beta1 Induces the Differentiation of Myogenic Cells into Fibrotic Cells in Injured Skeletal Muscle: a Key Event in Muscle Fibrogenesis

Overview

Journal Am J Pathol

Publisher Elsevier

Specialty Pathology

Date 2004 Feb 26

PMID 14982854

Citations 190

Authors

Yong Li

William Foster

Bridget M Deasy

Yisheng Chan

Victor Prisk

Ying Tang

James Cummins

Johnny Huard

Affiliations

Soon will be listed here.

Abstract

Transforming growth factor-beta1 (TGF-beta1) is thought to play a crucial role in fibrotic diseases. This study demonstrates for the first time that TGF-beta1 stimulation can induce myoblasts (C2C12 cells) to express TGF-beta1 in an autocrine manner, down-regulate the expression of myogenic proteins, and initiate the production of fibrosis-related proteins in vitro. Direct injection of human recombinant TGF-beta1 into skeletal muscle in vivo stimulated myogenic cells, including myofibers, to express TGF-beta1 and induced scar tissue formation within the injected area. We also observed the local expression of this growth factor by myogenic cells, including regenerating myofibers, in injured skeletal muscle. Finally, we demonstrated that TGF-beta1 gene-transfected myoblasts (CT cells) can differentiate into myofibroblastic cells after intramuscular transplantation, but that decorin, an anti-fibrosis agent, prevents this differentiation process by blocking TGF-beta1. In summary, these findings indicate that TGF-beta1 is a major stimulator that plays a significant role in both the initiation of fibrotic cascades in skeletal muscle and the induction of myogenic cells to differentiate into myofibroblastic cells in injured muscle.

Citing Articles

Melatonin ameliorates age-related sarcopenia by inhibiting fibrogenic conversion of satellite cell.

Zhu G, Zhao K, Li H, Wu D, Chen Y, Han D Mol Med. 2024; 30(1):238.

PMID: 39614149 PMC: 11607977. DOI: 10.1186/s10020-024-00998-2.

The Role of Ion-Transporting Proteins on Crosstalk Between the Skeletal Muscle and Central Nervous Systems Elicited by Physical Exercise.

Bertomeu J, Fioravanco L, Ramis T, Godinho D, Nascimento A, Lima G Mol Neurobiol. 2024; .

PMID: 39578339 DOI: 10.1007/s12035-024-04613-7.

A Novel Minimally Invasive Surgically Induced Skeletal Muscle Injury Model in Sheep.

Vidal L, Vila I, Venegas V, Sacristan A, Contreras-Munoz P, Lopez-Garzon M Int J Mol Sci. 2024; 25(11).

PMID: 38891800 PMC: 11171619. DOI: 10.3390/ijms25115612.

Relaxin as a treatment for musculoskeletal fibrosis: What we know and future directions.

Nourmahnad A, Shariyate M, Khak M, Grinstaff M, Nazarian A, Rodriguez E Biochem Pharmacol. 2024; 225:116273.

PMID: 38729446 PMC: 11179965. DOI: 10.1016/j.bcp.2024.116273.

Engineering Stem Cell Fate Controlling Biomaterials to Develop Muscle Connective Tissue Layered Myofibers.

Han S, Lee M, Rodriguez-delaRosa A, Kim J, Barroso-Zuppa M, Pineda-Rosales M Adv Funct Mater. 2024; 34(3.

PMID: 38707790 PMC: 11068219. DOI: 10.1002/adfm.202304153.

References

Lundberg I, Ulfgren A, Nyberg P, Andersson U, Klareskog L . Cytokine production in muscle tissue of patients with idiopathic inflammatory myopathies. Arthritis Rheum. 1997; 40(5):865-74. DOI: 10.1002/art.1780400514. View

Rodriguez-Barbero A, Obreo J, Yuste L, Montero J, Rodriguez-Pena A, Pandiella A . Transforming growth factor-beta1 induces collagen synthesis and accumulation via p38 mitogen-activated protein kinase (MAPK) pathway in cultured L(6)E(9) myoblasts. FEBS Lett. 2002; 513(2-3):282-8. DOI: 10.1016/s0014-5793(02)02337-2. View

Li Y, Han B, Li K, Jiao L, Habib N, Wang H . TGF-beta 1 inhibits HLA-DR and beta 2-microglobulin expression in HeLa cells induced with r-IFN. Transplant Proc. 1999; 31(5):2143-5. DOI: 10.1016/s0041-1345(99)00288-2. View

Bucala R, SPIEGEL L, Chesney J, Hogan M, Cerami A . Circulating fibrocytes define a new leukocyte subpopulation that mediates tissue repair. Mol Med. 1994; 1(1):71-81. PMC: 2229929. View

Waltenberger J, Lundin L, Oberg K, Wilander E, Miyazono K, Heldin C . Involvement of transforming growth factor-beta in the formation of fibrotic lesions in carcinoid heart disease. Am J Pathol. 1993; 142(1):71-8. PMC: 1886850. View

Lee S, McPherron A . Regulation of myostatin activity and muscle growth. Proc Natl Acad Sci U S A. 2001; 98(16):9306-11. PMC: 55416. DOI: 10.1073/pnas.151270098. View

Zhang H, Phan S . Inhibition of myofibroblast apoptosis by transforming growth factor beta(1). Am J Respir Cell Mol Biol. 1999; 21(6):658-65. DOI: 10.1165/ajrcmb.21.6.3720. View

Yang H, Kyo S, Takatura M, Sun L . Autocrine transforming growth factor beta suppresses telomerase activity and transcription of human telomerase reverse transcriptase in human cancer cells. Cell Growth Differ. 2001; 12(2):119-27. View

Dooley S, Delvoux B, Lahme B, Gressner A . Modulation of transforming growth factor beta response and signaling during transdifferentiation of rat hepatic stellate cells to myofibroblasts. Hepatology. 2000; 31(5):1094-106. DOI: 10.1053/he.2000.6126. View

10.

Lehto M, Jarvinen M, Nelimarkka O . Scar formation after skeletal muscle injury. A histological and autoradiographical study in rats. Arch Orthop Trauma Surg (1978). 1986; 104(6):366-70. DOI: 10.1007/BF00454432. View

11.

Honda H, Kimura H, Rostami A . Demonstration and phenotypic characterization of resident macrophages in rat skeletal muscle. Immunology. 1990; 70(2):272-7. PMC: 1384205. View

12.

Branton M, Kopp J . TGF-beta and fibrosis. Microbes Infect. 1999; 1(15):1349-65. DOI: 10.1016/s1286-4579(99)00250-6. View

13.

Kaname S, Ruoslahti E . Betaglycan has multiple binding sites for transforming growth factor-beta 1. Biochem J. 1996; 315 ( Pt 3):815-20. PMC: 1217279. DOI: 10.1042/bj3150815. View

14.

Brockes J . Amphibian limb regeneration: rebuilding a complex structure. Science. 1997; 276(5309):81-7. DOI: 10.1126/science.276.5309.81. View

15.

Pardali K, Kurisaki A, Moren A, Ten Dijke P, Kardassis D, Moustakas A . Role of Smad proteins and transcription factor Sp1 in p21(Waf1/Cip1) regulation by transforming growth factor-beta. J Biol Chem. 2000; 275(38):29244-56. DOI: 10.1074/jbc.M909467199. View

16.

Liu D, Black B, Derynck R . TGF-beta inhibits muscle differentiation through functional repression of myogenic transcription factors by Smad3. Genes Dev. 2001; 15(22):2950-66. PMC: 312830. DOI: 10.1101/gad.925901. View

17.

Sprugel K, McPherson J, Clowes A, Ross R . Effects of growth factors in vivo. I. Cell ingrowth into porous subcutaneous chambers. Am J Pathol. 1987; 129(3):601-13. PMC: 1899822. View

18.

Fukushima K, Badlani N, Usas A, Riano F, Fu F, Huard J . The use of an antifibrosis agent to improve muscle recovery after laceration. Am J Sports Med. 2001; 29(4):394-402. DOI: 10.1177/03635465010290040201. View

19.

Massague J, Cheifetz S, Endo T, Nadal-Ginard B . Type beta transforming growth factor is an inhibitor of myogenic differentiation. Proc Natl Acad Sci U S A. 1986; 83(21):8206-10. PMC: 386896. DOI: 10.1073/pnas.83.21.8206. View

20.

Border W, Noble N . Transforming growth factor beta in tissue fibrosis. N Engl J Med. 1994; 331(19):1286-92. DOI: 10.1056/NEJM199411103311907. View